Condition: Atrium; Fibrillation · Chronic Kidney Diseases · Sponsor: Hospital Sirio-Libanes
VISIONAIRE (Vitamin K AntagonISt, Factor Xa Inhibitor Or Nothing In Atrial Fibrillation And DIalytic End-stage Renal DiseasE) trial will be a prospective randomized open-label with blinded endpoint adjudication trial including 1500 patients with atrial fibrillation or atrial flutter and advanced chronic kidney disease
This description comes directly from the study's public registry record.
Lilian Barbosa, MBA · +55 11 98966 0550 · lilian@bcri.org.br
Always discuss trial participation with your own doctor first.
| Hospital Ana Nery | Salvador, Estado de Bahia, Brazil | Active Not Recruiting |
| Instituto de Cardiologia do DF | Brasília, Federal District, Brazil | Active Not Recruiting |
| Hospital Universitário Maria Aparecida Pedrossian - EBSERH | Campo Grande, Mato Grosso do Sul, Brazil | Active Not Recruiting |
| Sociedade Beneficente de Senhoras Hospital Sírio-Libanês | São Paulo, São Paulo, Brazil | Active Not Recruiting |
| Hospital Universitário São Francisco na Providência de Deus | Bragança Paulista, Brazil | Recruiting |
| Santa Casa de Misericórdia de Ponta Grossa | Ponta Grossa, Brazil | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06402851